Santa Barbara Nutrients is a dynamic player in the Biotechnology, Health Care, and Pharmaceutical industries, founded in 2020 in the United States. Their mission, "We are a team of dedicated researchers and patients bringing to market safe, science-backed products for kidney health," underscores their commitment to addressing kidney-related health issues through innovative solutions.
Backed by a team of seasoned kidney researchers and industry professionals, including those personally affected by kidney disease, the company offers a unique perspective on healthcare solutions. Their flagship product, KetoCitra, stands as the first medical food specifically targeting the dietary management of mild to moderate stages of autosomal dominant polycystic kidney disease (ADPKD).
Santa Barbara Nutrients received a $1.23M Early VC investment on 01 March 2021, which aids their ongoing mission to enhance kidney health awareness and provides a solid financial foundation for future growth and product development.